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We analysed STAT5A gene expression in breast cancer using the
Oncomine database. We exemplify four representative studies
showing that STAT5A is generally downregulated in breast cancer.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
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 We show that in different independent studies STAT5A is downregulated in breast cancer.
 The downregulation of STAT5A supports a tumour suppressor role for STAT5A in breast cancer and
is consistent with our recent discovery that STAT5A is a p53-target gene [2].
 High levels of STAT5A indicate a good prognosis in breast cancer and it assessment can be used in
the clinics as part of a multigene prognostic test (Fig. 1).Fig. 1. Downregulation of STAT5A expression in breast cancer (from Oncomine).
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We show that STAT5A is downregulated in breast cancer using several large-scale gene expression
analyses available at Oncomine: https://www.oncomine.org/resource/main.html [1].4. Experimental design, materials and methods
We used the publicly available Oncomine search to ﬁnd the status of STAT5A in breast cancer.Acknowledgements
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Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.02.073.References
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